Bill Text: IL HR1021 | 2021-2022 | 102nd General Assembly | Introduced
Bill Title: Urges state agencies to expand comprehensive cardiovascular screening programs to allow for earlier identification of patients at risk of cardiovascular events. Urges state agencies to explore ways to collaborate with federal and national agencies and organizations to establish or expand comprehensive cardiovascular screening programs. Urges an update of the State's cardiovascular plan to accelerate quality improvements in the care rendered to these patients such that screening, treatment, monitoring, and improved health outcomes are achieved. States support for the creation of policies to decrease the rising number of deaths of Americans as a result of ASCVD.
Spectrum: Bipartisan Bill
Status: (Passed) 2023-01-10 - Resolution Adopted by Voice Vote [HR1021 Detail]
Download: Illinois-2021-HR1021-Introduced.html
| |||||||
| |||||||
| |||||||
1 | HOUSE RESOLUTION
| ||||||
2 | WHEREAS, Cardiovascular disease (CVD) is the leading cause | ||||||
3 | of death in the United States, and African Americans have the | ||||||
4 | highest overall mortality rate from coronary heart disease | ||||||
5 | (CHD) of any ethnic group in the United States, particularly | ||||||
6 | in out-of-hospital deaths and at especially younger ages; and
| ||||||
7 | WHEREAS, According to the U.S. Census Bureau, | ||||||
8 | approximately 21 million patients have been diagnosed with | ||||||
9 | atherosclerotic cardiovascular disease (ASCVD) in the United | ||||||
10 | States and are at risk of experiencing a cardiovascular event; | ||||||
11 | and
| ||||||
12 | WHEREAS, The Mayo Clinic states that ASCVD is linked to | ||||||
13 | the build-up of cholesterol in the arteries and the risk of | ||||||
14 | associated events can be modified by lowering low-density | ||||||
15 | lipoprotein cholesterol (LDL-C); and
| ||||||
16 | WHEREAS, In 2016, nearly 70 million adults in the United | ||||||
17 | States had higher than recommended LDL-C levels; and
| ||||||
18 | WHEREAS, Approximately 43.1 million people in the United | ||||||
19 | States are currently being treated with lipid-lowering | ||||||
20 | therapies to manage cardiovascular risk; and
|
| |||||||
| |||||||
1 | WHEREAS, Only 20% of people with ASCVD who are taking | ||||||
2 | statins, one of the leading lipid-lowering therapies, actually | ||||||
3 | achieve healthy levels of LDL-C; and
| ||||||
4 | WHEREAS, The American Heart Association has indicated the | ||||||
5 | total direct and indirect cost of ASCVD in the U.S. was $555 | ||||||
6 | billion in 2016 with it being projected to climb to $1.1 | ||||||
7 | trillion by 2035; and
| ||||||
8 | WHEREAS, In Illinois, 776,900 adults have been told by a | ||||||
9 | health professional that they had angina, a stroke, a heart | ||||||
10 | attack, or coronary heart disease, which are some of the | ||||||
11 | manifestations of ASCVD; 363,500 adults have reported | ||||||
12 | experiencing a heart attack in their lifetime and 293,300 | ||||||
13 | adults have reported experiencing a stroke in their lifetime; | ||||||
14 | 13,484 people had ASCVD as an underlying cause of death; and
| ||||||
15 | WHEREAS, Illinois spends an estimated $4.59 billion | ||||||
16 | dollars on direct medical expenses for ASCVD care each year; | ||||||
17 | therefore, be it
| ||||||
18 | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | ||||||
19 | HUNDRED SECOND GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | ||||||
20 | we urge state agencies to expand comprehensive cardiovascular | ||||||
21 | screening programs to allow for earlier identification of | ||||||
22 | patients at risk of cardiovascular events; and be it further
|
| |||||||
| |||||||
1 | RESOLVED, That we urge state agencies to explore ways to | ||||||
2 | collaborate with federal and national agencies and | ||||||
3 | organizations to establish or expand comprehensive | ||||||
4 | cardiovascular screening programs; and be it further
| ||||||
5 | RESOLVED, That we urge an update of the State's | ||||||
6 | cardiovascular plan to accelerate quality improvements in the | ||||||
7 | care rendered to these patients such that screening, | ||||||
8 | treatment, monitoring, and improved health outcomes are | ||||||
9 | achieved; and be it further
| ||||||
10 | RESOLVED, That we support the creation of policies to | ||||||
11 | decrease the rising number of deaths of Americans as a result | ||||||
12 | of ASCVD; and be it further
| ||||||
13 | RESOLVED, That suitable copies be delivered to the | ||||||
14 | Governor, the Lieutenant Governor, the Director of the | ||||||
15 | Department of Public Health, the Director of the Department of | ||||||
16 | Healthcare and Family Services, and the Secretary of the | ||||||
17 | Department of Human Services.
|